Peptide Research Literature Index
A structured, dated index of the research-peptide landscape

Is a customer review on a seller's own website regulated? Two federal documents cover it, they share one definition almost word for word, and the difference is that one says should and the other says must

Reference page · published 2026-10-19

Disclosure: this index is operated by Artemis Labs, which sells research compounds to laboratories. Artemis Labs displays customer reviews on its own website, so this page is about a body of law that applies to us, and we have written it without leaving ourselves out of it. Nothing here is legal advice, and nothing here says whether any particular company, review, or advertisement does or does not violate anything. Every quotation below is verbatim from a federal regulation, a Federal Register notice, a section of the United States Code, or a document filed in a United States District Court. Each was fetched and read for this page on October 19, 2026, and each is listed under Sources with the byte count of the response we received. This page deliberately names no compound. The mechanism does not depend on what is in the bottle, and keeping compounds out of it is the point, not an omission.

Short answer: yes, and by two different instruments that are easy to confuse. The first is a set of Guides — 16 CFR Part 255, revised in 2023. The Guides say of themselves that they represent administrative interpretations of laws enforced by the Federal Trade Commission and that they provide the basis for voluntary compliance with the law by advertisers and endorsers. The second is a Rule — 16 CFR Part 465, effective October 21, 2024. A rule is a different kind of object: breaking it is itself the violation, and that opens a civil penalty route the Guides do not. You can see the Commission choosing its words. Both documents define the phrase clear and conspicuous, in sentences that are in places identical. In the Guides' definition the word should appears seven times and must appears zero. In the Rule's definition must appears ten times and should appears zero. The Rule also adds a sentence the Guides do not contain: a disclosure is not clear and conspicuous if a consumer must take any action, such as clicking on a hyperlink or hovering over an icon, to see it.

There is a second reason this page exists, and it is less comfortable. The Guides contain a sentence about what consumer reviews are worth as evidence: Consumer endorsements themselves are not competent and reliable scientific evidence. This index published a page yesterday about a different Commission document that says, in substance, that animal and laboratory-dish studies are not sufficient substantiation for a health claim either. Those are the two things a research-compound website usually has. Neither of them, on the Commission's own account, is the thing the Commission asks for.

What this index did not hold before today

We counted. Across the 110 pages built in this index as of October 19, 2026, the phrase 16 CFR 255 appears zero times. So do Part 255, 16 CFR 465, consumer review, fake review, material connection, incentivized review, star rating, verified buyer and influencer. The word endorsement appears on four pages, four times in total. Testimonial appears on eleven pages, fifteen times in total — and every one of those is about a different question: whether a customer's words can be used as evidence that a product is an unapproved drug. That is a food-and-drug question. The question on this page is an advertising question, and the index had nothing on it.

Those zeros are readings, not an absence of looking. The same count, run the same way over the same files, returns warning letter 767 times across 86 pages, misbranded 138 across 28, intended use 76 across 36 and research use only 57 across 22, while a deliberately invented control string returns zero. A matcher that finds the live terms and misses the dead one is working.

Two documents, two shelves, one definition

The clearest evidence that these are different kinds of law is where the government files them. Both parts sit in Title 16 of the Code of Federal Regulations, Chapter I, which is the Federal Trade Commission. They are in different subchapters. Part 255 is in Subchapter B — Guides and Trade Practice Rules. Part 465 is in Subchapter D — Trade Regulation Rules. We did not infer that from the text; we read it from the regulation's own ancestry record at eCFR, which is linked below.

Part 255 is titled Guides Concerning Use of Endorsements and Testimonials in Advertising and has seven sections, 255.0 through 255.6. Its opening section tells you what it is:

The Guides in this part represent administrative interpretations of laws enforced by the Federal Trade Commission for the guidance of the public in conducting its affairs in conformity with legal requirements. Specifically, the Guides address the application of section 5 of the FTC Act, 15 U.S.C. 45, to the use of endorsements and testimonials in advertising. The Guides provide the basis for voluntary compliance with the law by advertisers and endorsers. Practices inconsistent with these Guides may result in corrective action by the Commission under section 5 if, after investigation, the Commission has reason to believe that the practices fall within the scope of conduct declared unlawful by the statute.

Read that last sentence slowly. Breaking a Guide is not itself illegal. What is illegal is section 5 — unfair or deceptive acts or practices — and the Guides tell you how the Commission reads section 5 when the advertising uses someone else's words. The route from a Guide to a consequence runs through an investigation and a determination about the statute.

Part 465 is titled Rule on the Use of Consumer Reviews and Testimonials and has nine numbered sections, 465.1 through 465.9, one of which — 465.3 — is marked [Reserved]. That leaves eight operative sections, and seven of those eight open with the same eleven words: It is an unfair or deceptive act or practice and a violation of this part. The Rule does not interpret the prohibition. It is one.

The same definition, two different verbs

Both documents need to define clear and conspicuous, because both turn on disclosure. The two definitions cover the same ground in the same order, and in places the sentences match. Here is the internet sentence from each, side by side.

Part 255, the Guides: In any communication using an interactive electronic medium, such as social media or the internet, the disclosure should be unavoidable.

Part 465, the Rule: In any communication using an interactive electronic medium, such as social media or the internet, the disclosure must be unavoidable. A disclosure is not clear and conspicuous if a consumer must take any action, such as clicking on a hyperlink or hovering over an icon, to see it.

One word changes, and a sentence is added. We counted the modal verbs across each definition instead of trusting the impression those two sentences give. In the Guides' definition paragraph — 1,496 characters — should appears 7 times and must appears 0 times. In the Rule's definition — 1,926 characters — must appears 10 times and should appears 0. Controls on the same two slices: the word conspicuous appears twice in each, and an invented control string appears in neither, so the slices are real text and the zeros are readings.

We should not overstate this. Across each document as a whole the contrast is softer: Part 255 uses should 45 times and must 27 times, and Part 465 uses should 6 times and must 10 times. Part 255's uses of must are mostly in the substantiation obligations, where the Guides restate what section 5 already requires and add nothing. The sharp comparison is the definition, because that is the one passage where the two documents are doing the same job with nearly the same sentences, and it is the comparison we are making.

There is one more difference in the same family, and it is the one most likely to catch a website out. The Rule's definition requires that a disclosure appear in each language in which the representation that requires the disclosure appears. The Guides' definition contains no such sentence.

What the Guides say a review is

The Guides' most useful passage for a seller with a review section is an example about dog food, and the reason is that it draws the line at an act the seller performs. A customer buys a product with their own money and posts about it. That post, the Guides say, cannot be attributed to the manufacturer and the post would not be deemed an endorsement under the Guides, and the same is true of a review on an independent review website. Then:

But, if the consumer submits the review to the review section of the manufacturer's website and the manufacturer chooses to highlight the review on the homepage of its website, then the review as featured is an endorsement even though there is no connection between the consumer and the manufacturer.

Hosting is one thing; selecting is another. The customer did not change what they wrote. The seller changed what it was doing with it. This index has a record of the same logic arriving from the other agency, where a seller's amplification of a customer's review was read as the seller's own publication about its products. Two different statutes, two different agencies, one idea: when you pick a review up and put it somewhere, it becomes a thing you are saying.

From the same section, 255.2(a), the sentence that governs every claim a review can carry:

An advertisement employing endorsements by one or more consumers about the performance of an advertised product will be interpreted as representing that the product is effective for the purpose depicted in the advertisement. Therefore, the advertiser must possess and rely upon adequate substantiation, including, when appropriate, competent and reliable scientific evidence, to support express and implied claims made through endorsements in the same manner the advertiser would be required to do if it had made the representation directly, i.e., without using endorsements. Consumer endorsements themselves are not competent and reliable scientific evidence.

That is a closed loop. A review that says a product worked is read as a claim that the product works. The claim needs support. The review is not the support.

And then 255.2(d), which is the bridge from the Guides to the Rule, because it lists verbs rather than describing a document:

In procuring, suppressing, boosting, organizing, publishing, upvoting, downvoting, reporting, or editing consumer reviews of their products, advertisers should not take actions that have the effect of distorting or otherwise misrepresenting what consumers think of their products, regardless of whether the reviews are considered endorsements under the Guides.

Three examples in the Guides make that concrete, and none of them involve a fabricated review. In one, a retailer's product pages show an average star rating and a breakdown by rating. The Guides say that by doing so the website is representing that it is providing an accurate reflection of the views of the purchasers who submitted product reviews to the website, and then: If the retailer chose to suppress or otherwise not publish any reviews with fewer than four stars or reviews that contain negative sentiments, the product pages would be misleading as to purchasers' actual opinions of the products.

In another, a marketer asks recent purchasers for private feedback and then invites only the pleased ones to post publicly. The Guides say the practice may be an unfair or deceptive practice if it results in the posted reviews being substantially more positive than if the marketer had not engaged in the practice, and add that simply inviting all recent purchasers would not have been unfair or deceptive even if it had expressed its hope for positive reviews. The dividing line is not enthusiasm. It is whether the invitation was sorted by sentiment.

In the third, a marketer gives reviewers a free product and a payment, and makes clear they may write negative reviews. Each resulting review needs a disclosure of the incentive. Then the Guides go one step further than most readers expect:

Even if adequate disclosures appear in each incentivized review, the practice could still be deceptive if the solicited reviews contain star ratings that are included in an average star rating for the product and including the incentivized reviews materially increases that average star rating.

The disclosure fixes the review. It does not fix the number at the top of the page, because nobody reads a disclosure that lives inside a review when they look at an average.

The sentence that names both halves of the problem

Part 255's section on expert endorsements contains an example about a physician endorsing a product. The example turns on what the physician looked at before endorsing it, and the operative sentence is this:

If the materials the doctor reviewed were merely letters from satisfied consumers or the results of a rodent study, the endorsement would likely be deceptive because those materials are not the type of scientific evidence that others with the represented degree of expertise would consider adequate to support this conclusion about the product's safety and efficacy.

Letters from satisfied consumers, or the results of a rodent study. In one sentence, the Commission names the two categories of material that a research-compound website typically has the most of, and says that an expert relying on either would likely be making a deceptive endorsement. We publish dense citations to animal studies, and we publish customer reviews. This index takes the view that saying so plainly is worth more than the alternative, which is hoping the reader does not put the two documents side by side. The companion page on what the Commission accepts as substantiation sets out the other half of this in the Commission's own words.

What the Rule prohibits

Part 465 is short — eCFR serves the whole of it in 17,346 bytes of XML, against 77,017 for Part 255 — and it is worth knowing what the eight operative sections actually cover, because the popular name for it, the nickname fake reviews rule, describes only the first one.

Two carve-outs run through the Rule and matter more than their length suggests. Sections 465.2(b) and (c) do not apply to reviews that resulted from generalized solicitations to purchasers to post reviews or testimonials about their experiences, nor to reviews that appear merely because the business is hosting them. Asking all your customers to review you is not the conduct the Rule is aimed at, and neither is running a review section.

Definitions do a lot of work here. Purchase a consumer review is defined to include providing money, gift certificates, products, services, discounts, coupons, contest entries, or another review. A discount code is something of value. So is a free sample. So is a prize draw entry. The question the Rule asks is never whether money changed hands; it is whether anything of value was given in exchange for a review, and under 465.4, whether it was conditioned on the review having a particular sentiment.

The one the Commission decided not to make

Section 465.3 is reserved because the Commission dropped it. As proposed, it would have covered a business using or repurposing a consumer review written or created for one product so that it appears to have been written or created for a substantially different product. Commenters disputed what substantially different product meant, and one of them raised a disputed issue of material fact about the definition. The Commission's explanation is three sentences:

The Commission would need to address those concerns before finalizing the provision. As it is not able to resolve those concerns on the current rulemaking record, the Commission has decided not to finalize the provision. If the Commission chooses later to engage in further rulemaking regarding the provision, it will address the comments at that time.

This is the gap most relevant to a catalogue with many related items. Showing one product's reviews on a different product's page is not prohibited by Part 465, because the section that would have prohibited it does not exist. It is not thereby safe: 255.2(d)'s list of verbs includes organizing and publishing, section 5 is unchanged, and the Guides' whole subject is what a seller does with other people's words. What the gap means precisely is that the penalty route described in the next section does not reach it.

Why a rule and not more guidance: the money

The Commission says why, in its own preamble, and the reason is a Supreme Court case. In the discussion of the need for the rule, a footnote cites AMG Capital Management, LLC v. FTC, 593 U.S. 67, 82 (2021) — the decision this index records elsewhere, which held that section 13(b) of the FTC Act does not authorize equitable monetary relief. The preamble then says:

As an additional benefit, the rule will enable the Commission to seek civil penalties against violators. … Without an efficient way to seek civil penalties, bad actors have little fear of being penalized for using fraud and deception in connection with reviews and endorsements.

The ellipsis in that passage is a footnote marker in the original, not an omission of words.

And in a footnote, what the alternative looks like: Without the rule, the path to monetary relief is longer and requires the Commission to first conduct an administrative proceeding to determine whether the respondent violated the FTC Act — then a cease-and-desist order, then any appeal, then a separate federal court action in which the Commission must prove fraudulent or dishonest conduct. The rule collapses that.

Here is the part that completes something this index left open. Yesterday's page described the Commission's other post-AMG workaround: the Notice of Penalty Offenses, which exists because section 5(m)(1)(B) only reaches a company with actual knowledge that the Commission has already condemned the practice in a final order. The limit we recorded was that the notice route does not presently reach a seller who never received the notice. A rule has no such limit. Section 5(m)(1)(A) reaches anyone who violates a trade regulation rule with actual knowledge or knowledge fairly implied on the basis of objective circumstances. Nobody has to have been written to first. The published rule in the Federal Register is the notice.

There is a second money route alongside penalties. The preamble notes that any entity or person who violates such a rule (irrespective of the state of knowledge) is liable for any injury caused to consumers by the rule violation, recoverable under section 19(a)(1), 15 U.S.C. 57b(a)(1). Penalties require knowledge. Consumer redress does not.

On the size of a penalty, the preamble is careful, and so should anyone quoting it be. Answering a commenter who asked about the financial consequence of a fake review, the Commission wrote: The maximum civil penalty is currently $51,744 per violation, but courts must take into account the statutory factors set forth in section 5(m)(1)(C) of the FTC Act and may impose much lower per-violation penalties. It then adds: Ultimately, courts will also decide how to calculate the number of violations in a given case. Neither figure is a per-review price. The Commission says so itself in the same breath.

That $51,744 was the maximum in August 2024, and it has moved. The current table is 16 CFR 1.98, and the subsection matters more than the headline figure does, because this page turns on exactly which subsection applies. The section states that its amounts apply only to penalties assessed after January 17, 2025, including those penalties whose associated violation predated January 17, 2025. Paragraph (d) is the one a rule violation runs through — Section 5(m)(1)(A) of the FTC Act, 15 U.S.C. 45(m)(1)(A)—$53,088 — and paragraph (e) is the notice route this index described yesterday, Section 5(m)(1)(B) of the FTC Act, 15 U.S.C. 45(m)(1)(B)—$53,088. The amount is the same. The route is not: (e) needs a company that was sent a notice, and (d) does not.

One more thing about timing tells you these are different kinds of document. The revised Guides were published on July 26, 2023 and were Effective July 26, 2023 — the same day, nothing to wait for, because a statement of how an agency reads a statute does not change anyone's obligations. The Rule was published on August 22, 2024 and took effect on October 21, 2024, exactly 60 days later. That delay is what a legislative rule owes the people it binds.

The first case in this index that pleads the Rule

On May 11, 2026 — 567 days after the Rule took effect — the United States of America and the People of the State of Illinois, by Attorney General Kwame Raoul, filed a complaint in the United States District Court for the Northern District of Illinois against a home repair business and its principal. The case is United States of America v. B.E.S.T. GDR, LLC, No. 1:26-cv-05415, assigned to Judge Georgia N. Alexakis. It is not a peptide case, not a supplement case, and not a health case at all. It is here because of what it pleads.

The opening paragraph lists the instruments: section 5(a) of the FTC Act; the Rule on the Use of Consumer Reviews and Testimonials — which the complaint short-names the Reviews and Testimonials Rule — 16 C.F.R. Part 465; and the Gramm-Leach-Bliley Act. The Illinois Attorney General brings parallel counts under the Illinois Consumer Fraud and Deceptive Business Practices Act and the Illinois Uniform Deceptive Trade Practices Act. The United States seeks, among other things, civil penalties under section 5(m)(1)(A).

The conduct alleged is the fabrication case, not the shading case. The complaint alleges that the defendants artificially boost their consumer reviews and ratings by fabricating profiles of people to pose as customers of Defendants' invented companies, that images of real people were misappropriated to make those profiles look genuine, and — of one individual defendant — that He and his family have submitted fake reviews of Defendants' services. That last allegation is 465.2(c) and 465.5's territory: insiders and immediate relatives.

The structural detail worth carrying away is that the complaint pleads the same review conduct twice. Count III is headed Fake Reviews and is brought under section 5(a) of the FTC Act. Count IV is headed Reviews and Testimonials Rule Violations for Fake Reviews and is brought under Part 465. Same facts, two counts. That is the clearest available demonstration of what the Rule adds: not a new prohibition, but a second, faster door to money for conduct section 5 already covered.

What the evidence does not show

Quite a lot, and the single most important item is that the Rule count in that case is being contested on a ground that has nothing to do with whether the reviews were fake.

On July 17, 2026 the defendants moved to dismiss. Their brief characterizes Count IV as the USA's apparent attempt to circumvent AMG Capital Mgmt., LLC v. FTC — which, read against the Commission's own footnote citing the same case as a reason for the rulemaking, means both sides agree about what the Rule is for. Their argument is timing:

Count IV Must Be Dismissed: The Reviews and Testimonials Rule Cannot Be Applied Retroactively. … At the time of the January 2024 reviews, the Reviews and Testimonials Rule did not exist. … civil penalty exposure makes retroactive application particularly prejudicial.

The first sentence there is the heading of the brief's own argument, capitalised as the brief capitalises it.

The conduct they point to is alleged to have been completed in January 2024, which puts it between 264 and 294 days before the Rule's October 21, 2024 effective date, depending where in that month it fell. The brief says the month and not the day, so we give both ends of the interval instead of picking one. They cite the presumption against retroactivity and note that Nothing in 16 C.F.R. Part 465 or in the FTC's promulgating release states that the Rule applies to conduct occurring before October 21, 2024. The plaintiffs filed an opposition on August 7, 2026 and the defendants replied on August 21, 2026. As of the copy of the docket we read on October 19, 2026 — 59 days after briefing closed — no ruling on that motion appears. So the first Part 465 case this index holds has produced no decision about the Rule at all, and the only judicial statement about the Rule in this record is an argument that it should not apply.

That reading has a limit of its own, and here it is. The docket we read is the RECAP mirror at CourtListener, which is populated by what members of the public have uploaded. An order can exist on PACER and be absent there. We are reporting what a specific copy of the docket shows on a specific date, not the contents of the court's file.

The objections on the rulemaking record were substantial, and the Commission moved in response to some of them. One trade association argued that rulemaking raises serious First Amendment concerns, that the record did not establish reviews as a defined trade, that the FTC should not promulgate a rule solely because the augmented penalties attendant to a rule violation could ostensibly advance a Commission goal generally, and that the Commission had failed to show prevalence from enforcement actions many of which were settled by consent order. On the insider provision, commenters objected that it prohibited insiders' reviews regardless of whether that speech is deceptive in context; the Commission narrowed 465.5 by limiting it to material relationships and by adding, in 465.5(b), the qualifier that the relationship is not otherwise clear to the audience. On review suppression, a commenter argued that 465.7(a) was not narrowly tailored to serve a compelling state interest; the Commission added a scienter requirement, so the final text reaches a public false accusation only where it was made with the knowledge that the accusation was false or made with reckless disregard as to its truth or falsity. A rule that was narrowed three times during drafting is a rule whose edges are still being found.

The Commission received 100 comments on the proposed rule — its own count, of responsive and non-duplicative submissions — after 42 on the earlier advance notice and 7 on the informal hearing notice. The Federal Register document is signed By direction of the Commission and records no vote tally and carries no separate commissioner statement. We are not able to tell you from this document whether the Commission was unanimous, and we are not going to guess.

We looked for a court challenge to the Rule itself and did not find one. Searching CourtListener's federal court records for the phrase Consumer Reviews and Testimonials returned 19 matching dockets, and for 16 C.F.R. Part 465 returned 8. None is a petition for review of Part 465. The one appellate challenge to an FTC trade regulation rule that surfaced in those results, Custom Communications, Inc. v. Federal Trade Commission in the Eighth Circuit, concerns a different rule. We also checked the Federal Register for any document amending, staying or delaying Part 465: there are 4, and all four are the rulemaking documents themselves — the 2022 advance notice, the 2023 proposal, the 2024 hearing notice and the 2024 final rule. That is a search result, not a proof of absence. We are reporting what we looked for and what came back.

Being subject to a rule is not an accusation. Part 465 applies to every business that sells products or services and displays reviews, which is most of retail and includes this one. Nothing on this page says that any company named here, or any company not named here, has violated anything. The only allegations described above are allegations in a complaint that the defendants have moved to dismiss.

A third instrument, about contracts instead of advertising

A footnote in the Guides points at something neither Part 255 nor Part 465 covers. The Consumer Review Fairness Act, 15 U.S.C. 45b, makes certain contract terms void, and does not touch advertising at all. It defines a covered communication as a written, oral, or pictorial review, performance assessment of, or other similar analysis of, including by electronic means, the goods, services, or conduct of a person by an individual who is party to a form contract, and voids a form-contract provision that prohibits or restricts the ability of an individual who is a party to the form contract to engage in a covered communication or that imposes a penalty or fee against an individual who is a party to the form contract for engaging in a covered communication.

The statute carries its own carve-outs, and reading them next to 465.7(b)(1) is instructive: both let a seller remove content that contains someone's personal information or likeness, that is libelous, harassing, abusive, obscene, vulgar or sexually explicit, that is discriminatory with respect to intrinsic characteristics, or that is unrelated to the goods or services offered. The rule and the statute were drafted years apart and arrive at nearly the same list, which is a reasonable indication of where the settled ground is: you may take down a review for what it contains, applied evenly, and not for what it says about you.

The questions these documents put to any seller with a review section

We are not going to turn a federal rule into a checklist with ticks on it, because a checklist implies that completing it settles something, and these documents settle nothing in advance. What the three instruments do is ask a small number of answerable questions. Every one of them is a question about an act the seller performs, not about what a customer wrote.

  1. Does anything of value move toward a review? Under the definition in 465.1(m), value includes discounts, coupons, free product and contest entries, not just money. Under 465.4 the violation attaches when the incentive is conditioned expressly or by implication on a particular sentiment.
  2. Who, inside the business, has written one? Officers, managers, employees, agents and their immediate relatives are each named in 465.2(c) and 465.5, with different tests and different disclosure duties.
  3. Is anything filtered, and on what rule? 465.7(b) permits filters applied equally to all reviews submitted without regard to sentiment and lists them. A filter nobody has written down is a filter nobody can show was applied evenly.
  4. Does the displayed set claim to be the whole set? That claim can be implied by an average and a count, as the Guides' camping-goods example describes.
  5. Where does a disclosure live? Under the Rule, behind a hyperlink or a hover is not clear and conspicuous. That sentence is in the Rule and not in the Guides.
  6. What claim is the review making for the product? This is the one with no procedural answer. Under 255.2(a) the claim in a review is read as the seller's claim, it needs substantiation, and the review is not the substantiation.

The sixth question is the hard one for this industry, and it is hard in a way the first five are not. A seller can audit incentives, insiders, filters and disclosure placement. What a seller cannot do is make a customer's account of what a compound did into evidence that it does it. On the Commission's account, that material is not competent and reliable scientific evidence, and neither — per the guidance described on the companion page — is the animal and laboratory-dish literature that research-compound pages are built from. The honest conclusion is not that reviews are dangerous. It is that a review is a record of someone's experience and nothing more, and that a page which lets a review do the work of evidence has substituted one for the other.

How this page was made, and what it cannot tell you

Seventeen network responses were fetched and archived on October 19, 2026. Two of them are reported here as failures, not quietly dropped, because each is a trap worth naming.

An HTTP 200 is not the document you asked for. A request to the United States Code site at uscode.house.gov for 15 U.S.C. 45b returned HTTP 200 and 5,792 bytes, and the body is a page headed Page Not Found, with a notice that the site is currently operating in a temporary format. Nothing on this page rests on it. The text of 15 U.S.C. 45b quoted above comes from govinfo.gov instead, which returned the section.

A filter that is ignored returns a plausible answer. Our first attempt to read the docket passed docket_id as a query parameter to CourtListener's search endpoint. It returned HTTP 200 and a result count of 497,754,270 — the whole corpus, with the filter silently discarded, and the first rows carried dates in the year 3926. Re-issued as a search term instead of a parameter, the same endpoint returned 31 entries for this docket. Nothing from the first payload is reported on this page. A count that large is obvious; a filter silently dropped on a narrower query would not have been.

Two further limits belong here. ftc.gov was not reachable from this host. The agency's own site returned HTTP 404 for every path we tried, including its homepage, which is the same condition recorded yesterday. So no document on this page comes from ftc.gov. Everything attributed to the Commission comes from the Code of Federal Regulations as published by eCFR, or from the Federal Register, which are the official texts in any case. And the regulations quoted here are the versions in force on the dates stated: Part 255 as issued at 88 FR 48102 on July 26, 2023, and Part 465 as issued at 89 FR 68077 on August 22, 2024, both read from eCFR's edition current to October 1, 2026.

Finally, the obvious limit. This page describes what three federal instruments say. It does not describe how any of them has been applied, because with one contested exception they have not been, at least not in any record we were able to find. A rule two years old with no decided case under it is a rule whose meaning is still mostly on paper.

Sources

Every document below was fetched on October 19, 2026 and archived. The byte count stated with each is the size of the response we received. The two responses that were fetched and not used are listed too, with the reason, because a source list that silently omits its failures is less useful than one that does not.

How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.